Global Anthracyclines Market, By Drugs (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin), Dosage (Powder, Capsule, Solution, Injection, Suspension, Others), Route of Administration (Oral, Intravesical, Intravenous, Other), Mechanism of Action (Enzyme Interaction, DNA Intercalation, Reactive Oxygen Species (ROS), DNA Adduct Formation), Application (Acute lymphocytic leukemia, Acute myelogenous leukemia, Hodgkin's lymphoma, Non-Hodgkin's lymphoma, Bladder cancer, Breast cancer, Other metastatic cancers), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Global anthracyclines market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.90% in the above mentioned forecast period.
Anthracycline is a type of antibiotic which is extracted from various types of Streptomyces bacteria. Anthracyclines are used for the treatment of types of cancer. It acts by damaging the DNA of cancer cells and terminate its function. They do so in two ways: by intercalating into the base pairs in the DNA minor grooves and by causing free radical damage of the ribose in the DNA.
Rise in the prevalence of cancer patients across the world, rise in healthcare expenditure, emerging market and growing government initiatives for spreading awareness about the disease are the factors that will expand the global anthracyclines market.
Rising R&D activities and ongoing clinical trials will provide beneficial opportunities for the global anthracyclines market in the forecast period of 2021-2028.
Side effects of medication such as bleeding, skin ulcer, tissue necrosis, and others, complications associated with drug usage are the factors that will hamper the market growth and will further challenge the global anthracyclines market in the forecast period mentioned above.
This anthracyclines market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global anthracyclines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Anthracyclines Market Scope and Market Size
The anthracyclines market is segmented on the basis of drugs, treatment, dosage, route of administration, mechanism of action, application, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drugs, the anthracyclines market is segmented into daunorubicin, doxorubicin, epirubicin, idarubicin, mitoxantrone, and valrubicin.
- On the basis of dosage, the anthracyclines market is segmented into powder, capsule, solution, injection, suspension, and others.
- On the basis of route of administration, the anthracyclines market is segmented into oral, intravesical, intravenous and other.
- On the basis of mechanism of action, the anthracyclines market is segmented into enzyme interaction, DNA intercalation, reactive oxygen species (ROS), and DNA adduct formation.
- On the basis of application, the anthracyclines market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, Hodgkin’s lymphoma, non-Hodgkin's lymphoma, bladder cancer, breast cancer and other metastatic cancers.
- On the basis of end-users, the anthracyclines market is segmented into clinic, hospital and others.
- The anthracyclines market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Global Anthracyclines Market Country Level Analysis
Global anthracyclines market is analyzed, and market size information is provided by the country, drugs, treatment, dosage, route of administration, mechanism of action, application, end-users, and distribution channel as referenced above.
The countries covered in the global anthracyclines market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the anthracyclines market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of cancer and increasing awareness in this region. Global anthracyclines market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, growing awareness, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global anthracyclines market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Anthracyclines Market Share Analysis
Global anthracyclines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global anthracyclines market.
The major players covered in the global anthracyclines market report are AstraZeneca, Lilly, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Meiji Holdings Co., Ltd., MicroBiopharm Japan Co., Ltd, Synbias Pharma, Hikma Pharmaceuticals PLC, and Cumberland Pharmaceuticals Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Anthracyclines Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.